Latest Breaking News On - Seungyong yoon - Page 1 : comparemela.com

/PRNewswire/ Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of.

Kyonggi doSouth koreaJanssen pharmaSeungyong yoonKyung hoon hwangTaeyoung yoonUniversity of ulsan college medicineYuhan corpAsan medical centerPrnewswire oscotec incOscotec incMild cognitive impairmentClinical investigationUlsan collegeHoon hwangOscotec inc